Evaluation of NT-ProBNP marker to predict the cardiovascular risk in individuals with type 2 diabetes.
Not Applicable
- Conditions
- Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
- Registration Number
- CTRI/2023/12/060795
- Lead Sponsor
- Roche Diagnostics
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Type 2 diabetes mellitus patients with or without cardiovascular disease of either gender.
Exclusion Criteria
Subjects who had cancer and renal dysfunction, Pregnancy, Subjects with valvular, rheumatic, and congenital heart disease
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method